ArticleThe Journal of clinical investigation2025

Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.

Shu-Qiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.